Wegovy FlexTouch Pen

Wegovy is a prescription weight loss injection containing semaglutide. It is used alongside a reduced-calorie diet and increased physical activity to help adults with obesity or weight-related health conditions lose weight and maintain results.

Wegovy works by mimicking the natural GLP-1 hormone, which helps regulate appetite, food intake, and feelings of fullness. This helps reduce hunger and supports long-term weight loss.

Yes. Wegovy is a UK-licensed prescription-only medicine. It is available through regulated healthcare providers following an online or in-person medical consultation.

Wegovy can only be obtained with a valid prescription. You must complete a medical assessment with a licensed prescriber before it can be prescribed.

Yes, Wegovy can be prescribed online through regulated UK pharmacies and healthcare providers after an eligibility consultation. It cannot be purchased legally without a prescription.

The cost of Wegovy in the UK varies depending on the provider, dosage, and treatment plan. Pricing typically includes consultation, prescription, and medication supply.

Some patients may begin to notice appetite changes within the first few weeks. Significant weight loss is typically seen over several months when combined with diet and lifestyle changes.

Wegovy is started at a low dose and gradually increased over time to reduce side effects. The treatment is administered once weekly via a subcutaneous injection.

Common side effects include nausea, diarrhoea, constipation, and fatigue. These usually improve as the body adjusts to treatment.

Wegovy and Ozempic both contain semaglutide, but they are licensed for different uses. Wegovy is approved for weight management, while Ozempic is primarily used for type 2 diabetes.

Wegovy is suitable for adults with obesity (BMI criteria or weight-related health conditions) who have not achieved sufficient weight loss through diet and exercise alone.

Wegovy is not suitable for individuals with a personal or family history of certain thyroid cancers, pancreatitis, or those who are pregnant or breastfeeding. A medical assessment is required before prescribing.

Wegovy may be available through the NHS in limited cases depending on eligibility criteria. Private treatment is also available through licensed providers.